We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVTS:NASDAQNavitas Semiconductor Corporation Analysis

Data as of 2026-09-03 - not real-time

$11.10

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Navitas Semiconductor Corporation is priced at $11.10, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 7.7%. RSI sits at 38.5, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at $10.80 up to resistance at $14.95.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 26.8% above the current quote. Revenue is contracting at 27.3%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 95.8%, a beta of 4.69 and a maximum drawdown of 69.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.

Top Market Events

Navitas Semiconductor NVTS delivered earnings and revenue surprises of 0.Navitas beat both earnings and revenue for the seventh straight quarter as its AI infrastructure pivot accelerates,...Total revenue grew 22% sequentially with high-power markets growing more than 50% year-over-year and driving expanded...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 12.89
  • MACD momentum is negative
  • 30-day price change of -7.7%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 12.89
  • Analyst targets imply +26.8% versus the current price
  • 30-day volatility of 95.8%

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +26.8% versus the current price
  • Negative return on equity of -52.6%
  • Revenue contracting at -27.3%

Key Metrics & Analysis

Financial Health

Revenue Growth-27.30%
P/E Ratio-88.1
ROE-52.60%
ROA-8.99%
Debt/Equity0.64
P/B Ratio3.6
Op. Cash Flow$-66474000
Free Cash Flow$-3814750
Industry P/E35.7

Technical Analysis

TrendNeutral
RSI38.5
Support$10.80
Resistance$14.95
MA 20$12.77
MA 50$13.03
MA 200$12.89
MACDBearish
VolumeStable
Fear & Greed Index95.86

Valuation

Target Price$14.08
Upside/Downside26.80%
GradeFair
TypeBlend

Risk Assessment

Beta4.69
Volatility95.78%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.